Web-based Application to Test for Long-term Cognitive Deficits in BioCog Patients
Launched by CHARITE UNIVERSITY, BERLIN, GERMANY · Nov 29, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how cognitive abilities, or thinking skills, change over time in participants who were part of an earlier study called BioCog. The researchers aim to follow up with these individuals 7 to 10 years after they initially joined the study to see if they experience any long-term cognitive issues. Participants will take part in a medical check-in through phone or video calls and complete cognitive tests using a web-based application. They will also fill out questionnaires to share their experiences and opinions about using the online tools from home.
To be eligible for this study, participants must have been part of the BioCog cohort and should be able to provide informed consent for this follow-up. There are no specific age or gender restrictions, but participants should have had cognitive testing during the original study. The trial is currently looking for participants, so if you or someone you know fits these criteria, you might consider getting involved. This study not only aims to gather important data about cognitive health over time but also helps improve future care for individuals facing cognitive challenges.
Gender
ALL
Eligibility criteria
- • Patients
- Inclusion Criteria:
- • Patients of Berliner BioCog cohort with cognitive Testing (CANTAB Research Suite) at Baseline and with plasma samples for baseline that can be contacted.
- • Written informed consent for participation in the BioCog-Web study.
- • Data and reserve samples from patients in the Berlin BioCog cohort who can no longer be contacted.
- Exclusion Criteria:
- • None
- • Subjects
- Inclusion Criterion:
- • -BioCog subjects of the non-operated comparison cohort from Berlin with cognitive testing (CANTAB Research Suite) at baseline who are contactable
- Exclusion criteria:
- • -None
About Charite University, Berlin, Germany
Charité - Universitätsmedizin Berlin is a leading academic medical center in Germany, renowned for its commitment to excellence in research, education, and patient care. As one of Europe's largest university hospitals, Charité integrates cutting-edge clinical practices with innovative research initiatives, fostering interdisciplinary collaboration across various medical fields. The institution is dedicated to advancing healthcare through rigorous clinical trials, contributing to the development of new therapies and treatment protocols. With a strong emphasis on translational medicine, Charité aims to bridge the gap between scientific discovery and practical application, ultimately enhancing patient outcomes and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Berlin, , Germany
Patients applied
Trial Officials
Claudia Spies, MD, Prof.
Principal Investigator
Charitè - University Berlin
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported